Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02025 |
| Species: | Mus musculus |
| Position : | chr8:121519097-121520097 |
| Year: | 2022 |
| Title: | Cis interactions in the Irf8 locus regulate stage-dependent enhancer activation |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 36990511 |
| MONDO: | |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Myeloid progenitors |
| CVCL ID: | |
| Cell Type: | myeloid progenitor cell |
| Cell Ontology ID: | CL:0000837 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, Chromatin interaction assay |
| High Throughput Method: | RNA-seq, ATAC-seq, ChIP-seq, 4C-seq |
| Low Throughput Method: | CRISPR knockout, Transgenic reporter assay, RT-RT-qPCR |
| Target gene : | Irf8 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02026 | chr8:121519097-121520097 | Artery | vascular smooth muscle cell | -- |